Premium
Toward Labeled Argininamide‐Type NPY Y 1 Receptor Antagonists: Identification of a Favorable Propionylation Site in BIBO3304
Author(s) -
Keller Max,
Schindler Lisa,
Bernhardt Günther,
Buschauer Armin
Publication year - 2015
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/ardp.201400427
Subject(s) - chemistry , antagonist , neuropeptide y receptor , guanidine , residue (chemistry) , moiety , receptor , stereochemistry , biochemistry , neuropeptide
Aiming at molecular tools for the neuropeptide Y Y 1 receptor (Y 1 R), three types of derivatives of the argininamide‐type Y 1 R antagonist BIBO3304 were prepared by (i) propionylation at the guanidine group ( 3 ), (ii) substitution at the urea moiety with a propionamidobutyl residue ( 4 ), and (iii) replacement of ureidomethyl by a propionylaminomethyl group ( 5 ). With K i and K b values in the range of 1.5–4.3 nM, determined in binding and functional assays, and high selectivity for the Y 1 R over the Y 2 R, Y 4 R, and Y 5 R, compounds 4 and 5 were identified as promising candidates for radiolabeling by [ 3 H]propionylation according to established protocols.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom